Clinical Trial Update: First-line Dasatinib Plus Conventional Chemotherapy in Adults With Newly Diagnosed Ph-Positive ALL [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating first-line dasatinib in combination with conventional chemotherapy for adults with Philadelphia chromosome-positive acute lymphoblastic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Drugs mentioned

• Sprycel (dasatinib)

Snippet

Sponsor: The Catholic University of Korea | Conditions: Acute Lymphoblastic Leukemia | Phase 2 | Status: COMPLETED